DRUG · Mapped RxNorm record
Metformin Hydrochloride
Normalized identity: metformin hydrochlorideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
RCT Metformin for Reduction of Gestational Diabetes Mellitus Effects
NCT02980276
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedRCT Metformin for Reduction of Gestational Diabetes Mellitus Effects
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Metformin HydrochlorideDRUG · verified · RxNorm: metformin hydrochloride
PlaceboOTHER
Sponsors & collaborators
National University of Ireland, Galway, Irelandlead sponsor
Health Research Board, Irelandcollaborator
HRB Clinical Research Facility Galwaycollaborator
University College Hospital Galwaycollaborator
Portiuncula University Hospitalcollaborator
University Hospital of Limerickcollaborator
University Maternity Hospital Limerickcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02980276 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.